Hemoglobin variability in patients with chronic renal insuffiency;La variabilité de l'hémoglobine chez le patient dialysé

Nephrologie et Therapeutique

Volumn 4, Issue 7, 2008, Pages 549-552

  Deray, Gilbert ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Hemoglobin; Renal insufficiency; Variability

Indexed keywords

HEMOGLOBIN; IRON; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; CHRONIC INFLAMMATION; COMORBIDITY; ERYTHROBLASTOPENIA; HEMATOLOGIC DISEASE; HEMODIALYSIS PATIENT; HEMODILUTION; HEMOLYSIS; HOSPITALIZATION; HUMAN; HYPERPARATHYROIDISM; INFECTION; KIDNEY FAILURE; MORTALITY; SHORT SURVEY;

EPOETIN ALFA; HEMATINICS; HEMOGLOBINS; HUMANS; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS;

EID: 57049127577     PISSN: 17697255     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nephro.2008.04.010     Document Type: Short Survey

References (15)

1. Lacson E., Ofsthun N., and Lazarus M. Effect of variability in anemia managment on hemoglobin outcomes in ESRD. Am J Kidney Dis 41 (2003) 111-124
2. Beusterien K.M., Nissenson A.R., Port F.K., Kelly M., Steinwald B., and Ware J.E. The effects of recombinant human erythropoietin on functional health and well-being in chronic dialysis patients. J Am Soc Nephrol 7 (1996) 763-773
3. Massimetti C., Pontillo D., Feriozzi S., Costantini S., Capezzuto A., and Ancarani E. Impact of recombinant human erythropoietin treatment on left ventricular hypertrophy and cardiac function in dialysis patients. Blood Purif 16 (1998) 317-324
4. Locatelli F., Aljama P., Barany P., Canaud B., Carrera F., Eckardt K.U., et al. Revised european best practice guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant 19 Suppl. 2 (2004) ii1-ii44
5. KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis 2006; s1-145(Suppl. 3).
6. Fishbane S., and Berns J.S. Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietin. Kidney Int 68 (2005) 1337-1343
7. Ebben J.P., Gilbertson D.T., Foley R.N., and Collins A.J. Hemoglobin level variability: associations with comorbidity, intercurrent events, and hospitalizations. Clin J Am Soc Nephrol 1 (2006) 1205-1210
8. Collins A.J., Brenner R.M., Ofman J.J., Chi E.M., Stuccio-White N., Krishnan M., et al. Epoetin alfa use in patients with ESRD: an analysis of recent US prescribing patterns and haemoglobin outcomes. Am J Kidney Dis 46 (2005) 481-488
9. Berns J.S., and Fishbane S. Hemoglobin variability: random fluctuation, epiphenomenon, or phenomenon?. Semin Dial 19 3 (2006) 257-259
10. Ofsthun NJ, LaBrecque J, Keen M, Youngso HI, Krishnan M, Lazarus M. The association of mortality and hospitalization with haemoglobin (HB) and missed dialysis treatments in stage 5 chronic kidney disease (CKD) patients with and without cardiac comorbidities. European Renal Association/European Dialysis and Transplant Association Congress, Istanbul, 2005.
11. Gilbertson T., Ebben J.P., Bradbury B., Dunning S.C., and Collins A.J. The effect of hemoglobin (Hb) variability and trends on mortality. J Am Soc Nephrol 17 (2006) 582A
12. Feldman H., Israni K., Yang W., and Fishbane S. Hemoglobin variability and mortality among hemodialysis patients. J Am Soc Nephrol 17 (2006) 583A
13. Mueller H.J., Hahn K., Schneider H.W., Wanner Ch, and Mann J. Contributing factors to Hb-Cycling in a large cohort of ESRD patients in Germany. J Am Soc Nephrol 17 (2006) 579A
14. Pearce T, WilliamsJ, Aithal V, Adesina A, Brown C, Mikail A. Haemoglobin cycling in haemodialysis patients: effects of switch to subcutaneous epoetin beta. European Renal Association/European Dialysis and Transplant Association Congress, Glasgow, 2006;21(S4):iv154.
15. Chess J., Shrivastava R., Adesina A., Anand V., Williams J., Williams A., et al. Conversion to sc Epoetin Beta reduces frequency and amplitude of haemoglobin cycling in hemodialysis patients. J Am Soc Nephrol 17 (2006) 186A